| Literature DB >> 35206723 |
Abstract
The importance of varroosis control in a natural and sustainable way is crucial for beekeeping, having in view the varroa mite impact on honey bee health. In the last years, we developed a highly effective procedure for treating varroa in capped brood using volatile organic acids. This procedure can be applied at any moment of the active season as it uses organic substances. Taking into account the necessity to drastically reduce the level of varroa infestation in colonies before winter bee rearing, we developed a relatively simple pilot study to preliminarily test the impact of spring treatments on varroa infestation level in brood, to be evaluated in summer when, naturally, the population of mites increases. To test the hypothesis, two experimentally treated groups and a control group were used. The treatment consisted of brushing all capped brood with formic acid of 65% concentration in one and two applications. The obtained results show very significant differences between the treated and control groups in terms of infested cell percentages evaluated in the July-August period. Consequently, the spring treatments could be an important tool in limiting the varroa mite multiplication, but further experiments are necessary to test and adapt them to different local conditions.Entities:
Keywords: brushing procedure; capped brood; formic acid; honey bee; spring application; varroa
Year: 2022 PMID: 35206723 PMCID: PMC8875234 DOI: 10.3390/insects13020149
Source DB: PubMed Journal: Insects ISSN: 2075-4450 Impact factor: 2.769
The basic descriptive statistics of data regarding the percentage of varroa mite infested cells evaluated at different time intervals, in the experimental and control groups.
| Data Sets | Descriptive Statistics of Data Sets (Percentage of Infested Cells) | ||||||
|---|---|---|---|---|---|---|---|
| Mean | St. Dev | St. Err. | Min. | Max. | Counts | Counts | |
| Groups|Time Interval | |||||||
| T1|5–8 July | 1.40 | 0.87 | 0.27 | 0.25 | 3.00 | 10 | 400 |
| T1|20–22 July | 1.78 | 0.95 | 0.30 | 0.50 | 3.75 | 400 | |
| T1|16–18 August | 4.20 | 1.31 | 0.41 | 2.50 | 6.50 | 400 | |
| T2|5–8 July | 0.93 | 0.65 | 0.20 | 0.25 | 2.00 | 10 | 400 |
| T2|20–22 July | 1.58 | 1.01 | 0.32 | 0.25 | 2.75 | 400 | |
| T2|16–18 August | 3.25 | 1.30 | 0.41 | 0.75 | 4.50 | 400 | |
| T3 Control|5–8 July | 6.70 | 2.45 | 0.77 | 2.75 | 11.25 | 10 | 400 |
| T3 Control|20–22 July | 7.25 | 1.79 | 0.57 | 4.00 | 10.00 | 400 | |
| T3 Control|16–18 August | 9.28 | 4.07 | 1.29 | 3.50 | 15.50 | 400 | |
Figure 1The mean percentage of varroa mite infested cells evaluated in brood at different time intervals, as well as in different experimental groups.
Figure 2The box plotted data on the percentage of varroa mite infested cells evaluated in different experimental groups (T1, T2) as compared with T3 control in different time intervals: (a) 5–8 July 2021; (b) 20–22 July 2021; (c) 16–18 August 2021. The lines between treatments unite the mean values of each treatment and the central horizontal lines represent the median values.
The analysis of data variance applied on different data sets of treatments (groups) and evaluation time intervals at significance level 0.05 and 0.001.
| Levene’s Test | Test Value | Probability Level | Reject Equal Variances? | Reject Equal Variances? α = 0.001 | |
|---|---|---|---|---|---|
| 1 | 5–7 July 2021 | 6.389 | 0.005 | Yes | No |
| 2 | 20–22 July 2021 | 2.052 | 0.148 | No | No |
| 3 | 16–18 August 2021 | 6.491 | 0.005 | Yes | No |
The Welch’s ANOVA test of means, allowing for unequal variances of the different treatments grouped on the evaluation time interval.
| Welch’s ANOVA Test of Means Allowing for Unequal Variances | Numerator DF | Denominator | F-Ratio | Probability Level | Reject Equal Means? (α = 0.05) | Reject Equal Means? (α = 0.001) |
|---|---|---|---|---|---|---|
| Between treatments evaluated on: | ||||||
| 5–7 July 2021 | 2 | 16.03 | 24.99 | 0.000 | Yes | Yes |
| 16–18 August 2021 | 2 | 16.50 | 9.81 | 0.002 | Yes | No |
The one-way ANOVA test of means allowing for equal variances of the different treatments grouped on the evaluation time interval.
| One-Way ANOVA Test of Means Allowing Equal Variances | DF | Sum of Squares | Mean Square | F-Ratio | Probability Level | Reject Equal Means? |
|---|---|---|---|---|---|---|
| Between treatments evaluated on: | ||||||
| 5–7 July 2021 | 2/27 | 205.5 | 102.7 | 43.02 | 0.000 | Yes |
| 20–22 July 2021 | 2/27 | 207.4 | 103.7 | 60.79 | 0.000 | Yes |
| 16–18 August 2021 | 2/27 | 209.8 | 104.9 | 15.79 | 0.000 | Yes |
The Tukey–Kramer multiple-comparison test on the different treatments and different time intervals.
| Between Treatments | Evaluated on | |||
|---|---|---|---|---|
| 5–7 July | 20–22 July | 16–18 August | ||
| Groups | Counts | Means | ||
| T-1 | 10 | 1.4 | 1.78 | 4.2 |
| T-2 | 10 | 0.93 | 1.58 | 3.25 |
| T3 Control | 10 | 6.7 | 7.25 | 9.28 |
| Critical value = 3.51 (α = 0.05), critical value = 5.78 (α = 0.001) | ||||